Showing results (61-70 of 291) with videos related to

Sort By:
Pageof 30
Human Vaccines & Immunotherapeutics|February 11, 2015
Maintaining the momentum: key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemicBeth A Halperin, Donna MacKinnon-Cameron, Shelly McNeil, et al.
Protein Expression and Purification|September 5, 2006
Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coliMahdi Aminian, Sheila Sivam, Chiang W Lee, et al.
Infection and Immunity|March 26, 2003
Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric proteinSong F Lee, Scott A Halperin, Danny F Salloum, et al.
The Pediatric Infectious Disease Journal|July 3, 2008
Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007David W Scheifele, Julie A Bettinger, Scott A Halperin, et al.
Expert Review of Vaccines|May 11, 2013
Controlling serogroup B invasive meningococcal disease: the Canadian perspectiveJulie A Bettinger, Shelley L Deeks, Scott A Halperin, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 20, 2007
Invasive pneumococcal infections in Canadian children, 1998-2003: implications for new vaccination programsJulie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|January 9, 2010
Pertussis immunization in paediatric healthcare workers: knowledge, attitudes, beliefs, and behaviourKarina A Top, Beth A Halperin, Darlene Baxendale, et al.
Pageof 30